Christophe Schilling is the founder of Genomatica. Genomatica has raised $388M in total funding. Latest round: Series E. Backed by Novo Holdings.
Christophe Schilling is the Co-founder and CEO of Genomatica, a San Diego-based biotechnology company. He has guided the company through several funding rounds, including a $118 million Series E in 2021. Schilling advocates for early customer involvement and focused innovation in business development.
Full founder directory · Investor directory · Company funding database · Fundraising library